Purchase Order 36C26126P0159
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a purchase order to Edwards Lifesciences LLC on November 28, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants with a ceiling value of $32.5K. This firm fixed-price contract, which carries no set-aside designation, will be performed in San Francisco, California, and is scheduled for completion by December 1, 2025. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $32,500 firm fixed-price purchase order to Edwards Lifesciences LLC on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract has no set-aside designation and is scheduled for completion by February 2, 2026, with performance taking place in San Francisco, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a...
- Edwards Lifesciences LLC was awarded a $65,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) on October 28, 2025, for the procurement of transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract is scheduled for completion by January 27, 2026, and will be performed in San Francisco, California. This award was made without a set-aside designation and represents Edwards Lifesciences LLC's continued role as a specialized...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $43,151.47 firm fixed-price purchase order to Edwards Lifesciences LLC on December 16, 2025, for transcatheter aortic valve replacement (TAVR) prosthetics. This contract, which carries no set-aside designation, is scheduled for completion by January 15, 2026, with performance taking place in Palo Alto, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 23 for a TAVR (transcatheter aortic valve replacement) kit prosthetics delivery on October 24, 2025. The contract, valued at $34,000, is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The award supports the Department of Veterans Affairs'...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (VISN 23) on December 12, 2025. The contract, classified as a transcatheter aortic valve replacement (TAVR) procurement, has an ultimate completion date of December 15, 2025 and will be performed in Minneapolis, Minnesota. This award represents a non-competitive,...
- Edwards Lifesciences LLC has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) for prosthetics related to transcatheter aortic valve replacement (TAVR) procedures. The contract, awarded on December 8, 2025, has an ultimate completion date of January 8, 2026, and will be performed in Palo Alto, California. This purchase order represents a direct procurement of specialized cardiovascular medical devices from Edwards Lifesciences LLC, the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order contract by Veterans Integrated Service Network 20 on November 12, 2025, for prosthetics related to transcatheter aortic valve replacement (TAVR) technology. The contract, valued at $136,000 with an ultimate completion date of November 11, 2026, will be performed in Irvine, California. No set-aside designation was used...
Edwards Lifesciences LLC received a firm fixed-price purchase order valued at $32,500 from Veterans Integrated Service Network 21 for transcatheter aortic valve replacement (TAVR) surgical implants, with an ultimate completion date of February 11, 2026. The award was issued on November 12, 2025, with no set-aside designation and performance to be completed in San Francisco, California. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease medical innovations, the contractor specializes in advanced cardiovascular devices and is the sole manufacturer of the heart valve products required under this purchase order. This contract supports the Department of Veterans Affairs' mission to provide specialized surgical care to veteran populations through the Veterans Integrated Service Network system. Edwards Lifesciences LLC maintains multiple contracts with the VA, including two significant indefinite delivery contracts valued at $2.5 million and $1.25 million for various advanced cardiac devices and SAPIEN 3 Ultra transcatheter heart valves. The current purchase order reflects the ongoing demand for specialized cardiovascular surgical implants within the VA healthcare system and Edwards Lifesciences LLC's established role as a critical supplier of these specialized medical technologies to federal veteran healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 11/12/25 |